Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine.
about
Chronic Q fever in the United StatesEndocarditis due to rare and fastidious bacteriaQ feverQ fever endocarditis masquerading as Mixed cryoglobulinemia type II. A case report and review of the literatureCoxiella burnetii vascular graft infectionDevelopment of Liposomal Ciprofloxacin to Treat Lung InfectionsModulation of Host Autophagy during Bacterial Infection: Sabotaging Host Munitions for Pathogen NutritionQ28069944Genetics of Coxiella burnetii: on the path of specializationFrom Q Fever to Coxiella burnetii Infection: a Paradigm Change.The role of long-term doxycycline in patients of idiopathic pulmonaryfibrosis: The results of an open prospective trialCorrelation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray.Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease.Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherencePredominant immunoglobulin A response to phase II antigen of Coxiella burnetii in acute Q fever.Increases in the levels of Coxiella burnetii-specific immunoglobulin G1 and G3 antibodies in acute Q fever and chronic Q fever.Coxiella burnetii survives in monocytes from patients with Q fever endocarditis: involvement of tumor necrosis factorMolecular pathogenesis of the obligate intracellular bacterium Coxiella burnetiiEfficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.Characterization of a lipopolysaccharide-targeted monoclonal antibody and its variable fragments as candidates for prophylaxis against the obligate intracellular bacterial pathogen Coxiella burnetii.Large regional differences in serological follow-up of Q fever patients in the Netherlands.Role of doxycycline to resolve different types of non-malignant lung and pleural pathology: The results of a pilot observation.Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever.Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands.Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritisA Q Fever Outbreak in the Netherlands: Consequences for Tissue Banking.Q fever endocarditis in HIV-infected patientChronic Q fever diagnosis— consensus guideline versus expert opinionInfective endocarditis: a review of the best treatment options.Bartonella spp. and Coxiella burnetii Associated with Community-Acquired, Culture-Negative Endocarditis, Brazil.Treatment of Lyme disease: a medicolegal assessment.Chronic q Fever with no elevation of inflammatory markers: a case reportCoxiella burnetii infection in hemodialysis and other vascular grafts.Prevalence of chronic Q fever in patients with a history of cardiac valve surgery in an area where Coxiella burnetii is epidemicAntimicrobial therapies for Q fever.Low prevalence of Pneumocystis pneumonia in hospitalized patients with systemic lupus erythematosus: review of a clinical data warehouse.Emergence of q Fever.
P2860
Q24549147-A5A941CC-F2DD-4313-AE5C-7AFD7137155EQ24550691-880B9254-AA47-4EEC-BC88-9D1B72669E28Q24550722-9CE2F69D-32D9-4FD6-B54E-A8132381E9D0Q25257176-CC7EC9E0-5265-4862-ACEF-43A91EE6BAACQ25257645-08417A7D-450C-4643-B806-DB01002D7341Q26764772-5652D56C-5596-41DC-BE7B-03DC31294DE8Q26765914-5EF3FDA7-E06F-4DD2-9243-81F8867CF3C4Q28069944-8C813655-1060-4303-B883-446F7B85168FQ28655510-53492B30-E2C2-4DD6-BDD8-EFB48AD9A1A2Q30241105-DF967B21-D8F7-4570-826E-BFD80F54545CQ33822155-E6C3F94E-8D00-4299-B1F1-ABA291E81F42Q33883633-0E551718-6456-408C-929E-8BEF3CF289C2Q33943702-7CC4F694-93C9-45A1-8C17-F627DEEC9893Q33958858-AB6D6956-1512-4BD1-B561-6B94AC8B7B85Q33962064-15EEE713-0885-4633-81BB-08634A30D496Q33997618-308FF370-2844-44B5-A081-34808CF25F19Q33999603-33B224C4-80ED-46FD-8DC8-DD512B3D48FBQ34002996-0AE7778C-E1EA-4F04-85FF-403230E2B592Q34049976-F2FEBAF5-E42B-45B4-BB96-8D07FB60431DQ34057550-FAAA5AFC-CDC0-4046-964F-F60F4B944CAEQ34353780-C562D95C-AE2A-42E3-8121-5087DD1BAA09Q34596111-89B7AA1C-FE52-4CF3-A018-CE3FAC267254Q34663949-F8733606-393D-45F8-8250-60F1AF8FD313Q34984465-61194051-9D81-4175-B669-F9EB347373E0Q35077274-5A762490-8957-4F72-81E8-48F9BF5D905FQ35083804-68115231-DB02-4A5D-ACD8-8E04F6E5EA4AQ35615074-3BB1EAD1-5525-4099-9596-7B0FC7CEE368Q35655534-EC3FC889-96E2-40EB-B2FD-4327189CCADEQ35706578-4D9E10EC-126B-479D-B261-8AF332327D58Q35756375-700DB74E-2411-41A3-BAE2-2A284D13FE4FQ35780192-65890E2B-62CF-4775-A4F5-5FF9953E202BQ35871859-2F7CB714-9046-4713-A3EA-50FE630991D7Q35897120-395024E6-B3CA-4727-A55E-A10A789E59C5Q35917470-DC09B92C-26A1-4C31-8518-50C008C23BFBQ36076146-8AD3685D-1264-43F9-A74C-7523801D3C5EQ36150833-CD8C3888-EEEE-4724-BE48-0E15C70B22ACQ36154677-6A8B5119-7618-488B-900D-AEAD2538B802Q36169968-879B10C5-E27D-481C-99A1-C64E56458ED8Q36343593-0BF0DAC2-0A47-48E6-A2EC-029085B34635Q36348726-EBB3B9B5-18DB-4561-93D8-13D277792F95
P2860
Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Treatment of Q fever endocardi ...... loxacin or hydroxychloroquine.
@en
type
label
Treatment of Q fever endocardi ...... loxacin or hydroxychloroquine.
@en
prefLabel
Treatment of Q fever endocardi ...... loxacin or hydroxychloroquine.
@en
P2093
P1476
Treatment of Q fever endocardi ...... loxacin or hydroxychloroquine.
@en
P2093
Arditi-Djiane J
Houpikian P
Tissot Dupont H
P304
P356
10.1001/ARCHINTE.159.2.167
P407
P577
1999-01-01T00:00:00Z